Journal of the American Society of Hypertension
Volume 2, Issue 6 , Pages 410-417, November 2008

Increased vascular O-GlcNAcylation augments reactivity to constrictor stimuli — Vasoactive Peptide Symposium

  • Victor V. Lima

      Affiliations

    • Department of Physiology, Medical College of Georgia, Augusta, Georgia, USA
    • Corresponding Author InformationCorresponding author: Victor V. Lima, Medical College of Georgia, Department of Physiology, 1120 15th Street, CA-3141, Augusta, Georgia 30912. Tel: 706-721-0784; fax: 706-721-7299
  • ,
  • Fernanda R.C. Giachini, MSc

      Affiliations

    • Department of Physiology, Medical College of Georgia, Augusta, Georgia, USA
    • Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • ,
  • Fernando S. Carneiro, MSc

      Affiliations

    • Department of Physiology, Medical College of Georgia, Augusta, Georgia, USA
    • Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • ,
  • Zidonia N. Carneiro

      Affiliations

    • Department of Physiology, Medical College of Georgia, Augusta, Georgia, USA
  • ,
  • Zuleica B. Fortes, PhD

      Affiliations

    • Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • ,
  • Maria Helena C. Carvalho, PhD

      Affiliations

    • Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil
  • ,
  • R. Clinton Webb, PhD

      Affiliations

    • Department of Physiology, Medical College of Georgia, Augusta, Georgia, USA
  • ,
  • Rita C. Tostes, PhD

      Affiliations

    • Department of Physiology, Medical College of Georgia, Augusta, Georgia, USA
    • Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil

Received 5 March 2008; accepted 6 June 2008. published online 15 September 2008.

Abstract 

O-linked N-acetylglucosaminylation (O-GlcNAcylation) plays a role in many aspects of protein function. Whereas elevated O-GlcNAc levels contribute to diabetes-related end-organ damage, O-GlcNAcylation is also physiologically important. Because proteins that play a role in vascular tone regulation can be O-GlcNAcylated, we hypothesized that O-GlcNAcylation increases vascular reactivity to constrictor stimuli. Aortas from male Sprague-Dawley rats and C57BL/6 mice were incubated for 24 hours with vehicle or PugNAc (O-GlcNAcase inhibitor, 100 μM). PugNAc incubation significantly increased O-GlcNAc proteins, as determined by Western blot. PugNAc also increased vascular contractions to phenylephrine and serotonin, an effect not observed in the presence of Nω-nitro-L-arginine methyl ester or in endothelium-denuded vessels. Acetylcholine-induced relaxation, but not that to sodium nitroprusside, was decreased by PugNAc treatment, an effect accompanied by decreased levels of phosphorylated endothelial nitric oxide synthase (eNOS)Ser-1177 and AktSer-473. Augmented O-GlcNAcylation increases vascular reactivity to constrictor stimuli, possibly due to its effects on eNOS expression and activity, reinforcing the concept that O-GlcNAcylation modulates vascular reactivity and may play a role in pathological conditions associated with abnormal vascular function.

Keywords: PugNAc, eNOS, potassium chloride, phosphoinositide-3 kinase

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by the National Institutes of Health (HL74167), Bethesda, Maryland and CAPES, Brazil.

 VII International Symposium Vasoactive Peptide Symposium, February 14–16, 2008, Belo Horizonte, Brazil.

 Conflict of interest: none.

PII: S1933-1711(08)00129-0

doi:10.1016/j.jash.2008.06.001

Journal of the American Society of Hypertension
Volume 2, Issue 6 , Pages 410-417, November 2008